naltrexone has been researched along with Mouth Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, MW; Eisenstein, TK; Geller, EB; MacFarlane, AS; Meissler, JJ; Peng, X; Rogers, TJ | 1 |
Adler, MW; Eisenstein, LK; Hilburger, ME; MacFarland, AS; Meissler, LJ; Peng, X; Rahim, RT; Rogers, TJ; Wan, AC | 1 |
2 other study(ies) available for naltrexone and Mouth Diseases
Article | Year |
---|---|
Morphine increases susceptibility to oral Salmonella typhimurium infection.
Topics: Animals; Cytokines; Disease Susceptibility; Female; Germ-Free Life; Mice; Mice, Inbred C3H; Morphine; Mouth; Mouth Diseases; Naltrexone; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peyer's Patches; RNA, Messenger; Salmonella Infections, Animal; Salmonella typhimurium | 2000 |
Effect of opioids on oral Salmonella infection and immune function.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Drug Implants; Female; Immunosuppressive Agents; Infusion Pumps, Implantable; Mice; Mice, Inbred C3H; Morphine; Mouth Diseases; Naltrexone; Narcotic Antagonists; Narcotics; Oligopeptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Salmonella Infections, Animal; Salmonella typhimurium | 2001 |